Alimera Sciences (United States)
- Research works
- 75 ▼ 31% vs 2013–17
- Citations
- 781 10.4 per fractional work
- Top-10% rate
- 7.6% record average 16.5%
- Open access
- 31% world 28%
Not ranked overall: Alimera Sciences (United States) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.
Field profile
Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.
Rings at 0.5×, 1× and 2×. Widest outward: Biochemistry, Genetics and Molecular Biology, 4.6×. Every wedge is a field page.
- Biochemistry, Genetics and Molecular Biology 4.6×
- Immunology and Microbiology 3.8×
- Chemistry 3.0×
- Decision Sciences 1.9×
- Medicine 1.4×
- Mathematics 1.3×
- Agricultural and Biological Sciences 1.3×
- Engineering 1.1×
- Business, Management and Accounting 1.1×
- Computer Science 0.7×
- Arts and Humanities 0.3×
- Environmental Science 0.2×
- Materials Science 0.2×
- Social Sciences 0.2×
- Economics, Econometrics and Finance 0.1×
Which keywords describe research at Alimera Sciences (United States)?
By fractional works in 2022–2025, weighted toward what it does more of than the world: Gene Therapy, Healthcare, Diabetic Retinopathy, Macular Degeneration, Biomedical Engineering, Hackathons, Innovation and AAV.
- RNA-Guided
- Inflammation
- Oxidative Stress
- Glaucoma
- Viral Vectors
- Hackathons
- Innovation
- Macular Degeneration
- Healthcare
- Gene Therapy
- Diabetic Retinopathy
- Education
- Biomedical Engineering
- AAV
- Deep Learning
- Optic Nerve
- Genome Engineering
- Monoclonal Antibodies
Size is fractional works in 2022–2025 in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 18 words are chosen for being large and distinctive. Each links to the topic it comes from most.
All 18 words, with their numbers
- Gene Therapy2▲ 49×2 topics
- Healthcare2▲ 7.6×2 topics
- Diabetic Retinopathy2▲ 80×2 topics
- Macular Degeneration2▲ 66×2 topics
- Education2▲ 4.3×2 topics
- Innovation2▲ 7.0×2 topics
- Biomedical Engineering2▲ 47×1 topic
- Hackathons2▲ 190×1 topic
- AAV1▲ 156×1 topic
- Viral Vectors1▲ 156×1 topic
- Deep Learning1▲ 1.59×3 topics
- Glaucoma1▲ 34×2 topics
- Optic Nerve1▲ 51×2 topics
- Oxidative Stress1▲ 3.2×2 topics
- Genome Engineering1▲ 73×1 topic
- Inflammation1▲ 2.3×3 topics
- Monoclonal Antibodies1▲ 52×2 topics
- RNA-Guided1▲ 73×1 topic
Which research topics does Alimera Sciences (United States) publish most on?
By volume in 2022–2025: Biomedical and Engineering Education, Virus-based gene therapy research, CRISPR and Genetic Engineering and Retinal Diseases and Treatments.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 Biomedical and Engineering Education Biomedical Engineering 2 works
- 2 Virus-based gene therapy research Genetics 1 works
- 3 CRISPR and Genetic Engineering Molecular Biology 1 works
- 4 Retinal Diseases and Treatments Ophthalmology 1 works
- 5 Retinal Imaging and Analysis Radiology, Nuclear Medicine and Imaging 1 works
- 6 Biosimilars and Bioanalytical Methods Immunology 1 works
- 7 RNA Interference and Gene Delivery Molecular Biology 1 works
- 8 Viral gastroenteritis research and epidemiology Infectious Diseases 1 works
- 9 RNA Research and Splicing Molecular Biology 0 works
- 10 Icing and De-icing Technologies Aerospace Engineering 0 works
How open and international is its research?
Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 28% of research is openly available.
World: 19% is written across borders.
How has Alimera Sciences (United States)'s research output changed?
Output in 2018–2022 was 31% lower than in 2013–2017.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Other research institutions in Alpharetta
- Pediatrics and Genetics
- Engineering Associates (United States)
- Institute for Advanced Medical Research
- Chinese Medical Center
- Biota Pharmaceuticals (United States)
- Clearside Biomedical (United States)
- Veloxiti (United States)
- Rolta (United States)
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.